Insider Transactions in Q4 2025 at Adverum Biotechnologies, Inc. (ADVM)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
522,666
-100.0%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
500,000
+48.89%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
25,000
-100.0%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
351,513
-100.0%
|
-
|
|
Dec 09
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Exercise of conversion of derivative security
|
Direct |
150,000
+29.91%
|
$600,000
$4.2 P/Share
|
|
Dec 09
2025
|
Rabia Gurses Ozden Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
85,000
-100.0%
|
-
|
|
Dec 09
2025
|
Rabia Gurses Ozden Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+50.0%
|
-
|
|
Dec 09
2025
|
Rabia Gurses Ozden Chief Medical Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,125
-100.0%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
157,333
-100.0%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
150,000
+48.81%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,125
-100.0%
|
-
|
|
Dec 09
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
80,189
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
42,000
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
42,000
+50.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,125
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
61,150
-100.0%
|
-
|
|
Dec 09
2025
|
Linda M Rubinstein CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
48,750
+44.36%
|
$195,000
$4.2 P/Share
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
88,332
-100.0%
|
-
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
85,000
+49.04%
|
-
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,125
-100.0%
|
-
|
|
Dec 09
2025
|
Setareh Seyedkazemi CHIEF DEVELOPMENT OFFICER |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
54,874
-100.0%
|
-
|
|
Dec 09
2025
|
Dawn Svoronos |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,000
-100.0%
|
-
|
|
Dec 09
2025
|
Lupher, Jr. Mark L. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
13,000
-100.0%
|
-
|
|
Dec 09
2025
|
James Paul Scopa |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
10,333
-100.0%
|
-
|
|
Dec 09
2025
|
Patrick Machado |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
8,818
-100.0%
|
-
|
|
Dec 09
2025
|
Frazier Life Sciences Public Fund, L.P. |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
4,288,949
-100.0%
|
$12,866,847
$3.56 P/Share
|
|
Dec 08
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct |
117,614
+36.85%
|
$470,456
$4.31 P/Share
|
|
Dec 05
2025
|
Peter Soparkar CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
50,000
+38.41%
|
$200,000
$4.22 P/Share
|
|
Dec 05
2025
|
Laurent Fischer CEO, PRESIDENT AND DIRECTOR |
BUY
Open market or private purchase
|
Direct |
11,085
+11.67%
|
$44,340
$4.24 P/Share
|
|
Dec 04
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
524,560
-21.13%
|
$2,098,240
$4.19 P/Share
|
|
Dec 03
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
222,925
-8.41%
|
$891,700
$4.17 P/Share
|
|
Dec 02
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
51,961
-1.88%
|
$207,844
$4.2 P/Share
|
|
Dec 01
2025
|
Braden Michael Leonard |
SELL
Open market or private sale
|
Indirect |
300,000
-9.81%
|
$1,200,000
$4.2 P/Share
|